Skip to main content

Clinical trial SIENDO/ENGOT-EN5

A randomized phase III trial of maintenance with Selinexor / placebo after combination chemotherapy for patients with advanced or recurrent endometrial cancer

Organ Endomètre
Trial status Trial open for recruitment
Trial type
Interventional with experimental drug
Phase Trial phase 3
Academic trial Non
Sponsor Karyopharm
EudraCT Identifier 2017-000607-25
Last update